BiotechTube
Home/Sedivention/Ann-Kathrin Waldmann
AW

Ann-Kathrin Waldmann

Business Development / Business Intelligence

Sedivention

Therapeutic Areas

Obesity

Sedivention Pipeline

DrugIndicationPhase
Cryo-ablation Therapy for ObesityObesityPre-clinical

Leadership Team at Sedivention

DA
Dr.-Ing. Andreas Bröcker
CEO, Co-Founder
DM
Dr. med. Ute Nollert
CMO, Founder
AB
André Burch, EMBA
Co-Founder
JW
Jakob Wintermeyer
Corporate Fundraising / Investor Management
SN
Sara Nehmeier
Marketing Manager
View full Sedivention profile